Endotherapeutics Launches Social Impact Program with Children’s Cancer Institute Partnership
At Endotherapeutics, we believe that innovation in healthcare should be matched by a commitment to community. We are proud to officially launch the Endotherapeutics Social Impact Program, naming Children’s Cancer Institute as our primary charity partner.
About Our Partner: Children’s Cancer Institute
Children’s Cancer Institute is the only independent medical research institute in Australia wholly dedicated to curing childhood cancer. Their “bench-to-bedside” approach ensures that laboratory breakthroughs are translated into life-saving treatments for children as quickly as possible.
Turning Revenue into Research
Our partnership is built on a sustainable, target-driven giving model. To ensure our commercial success directly contributes to life-saving advancements, Endotherapeutics has committed to supporting and donating directly to Children’s Cancer Institute.
These funds will support the Institute’s essential research, accelerating the journey from laboratory discovery to clinical treatment for children facing cancer.
